Products

Kotoma

A focus timer with a face.

kotoma.app Productivity & Collaboration / Habits, Focus & Time Tracking

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$5.99/mo
Lower than 50% of peersNiche median $6/mo
Creators
L Siraj
No social account linked
Launched
23d ago
2026-10-27 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    a focus timer with a face

    Oct 27 · 23d agoLaunch page

    At the time: <5K visits/mo

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-10-24

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Kotoma
$5.99/once
Runs on macOS 26 or later.

Trial: None · 1 paid tier ($5.99) · Observed 2026-11-06 · Source page

Entry price $5.99/mo, Lower than 50% of peers; “Habits, Focus & Time Tracking” median is $6/mo.View pricing benchmark

Pages & changes

Tracked since 2026-10-27

Key pages

Weekly snapshots
Home
kotoma.app/ Snapshot 2026-11-06

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Kotoma cost?
Kotoma: $5.99/once. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Kotoma get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Kotoma and what platforms does it support?
Kotoma is catalogued under Habits, Focus & Time Tracking: A focus timer with a face. Supported platforms: Web.

Related products in this category

Productivity & Collaboration / Habits, Focus & Time Tracking

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.